OVERVIEW

Update on Inhaled and Rapid Acting Insulins: New Clinical Trial Data, What Patients Can Benefit, and How to Maximize Success is organized by Taking Control of Your Diabetes (TCOYD).

Term Offering: This activity was released on 8/2/2022 and is valid for one year. Requests for credit must be made no later than 8/2/2023.

Description:
Are your patients with diabetes struggling to control their postprandial glucose levels, leading to elevated HgbA1c levels? As endocrinologists both seeing patients with diabetes and living with diabetes themselves, Drs. Steve Edelman and Jeremy Pettus understand the daily frustrations of staying in range, recognizing the need for corrective insulin doses and delayed hypoglycemia. In this brand new online CME activity, Drs. Edelman and Pettus will introduce the latest clinical data and real case studies to compare rapid, ultra-rapid and inhaled insulin, and discuss which patients could most benefit from these therapies. They’ll also explain how to overcome the typical obstacles to prescribing inhaled insulins, so you can help your patients improve their diabetes management. Live Q&A with the experts included!

Learning Objectives:
After Completing This Activity Participants Will Be Able to:
Describe the Unmet Need Ultra-rapid Insulins Address in the Management of Type 1 and Type 2 Diabetes
Understand Clinical Trial Data for the Safety and Efficacy of Inhaled Insulin
Identify Patients That Could Benefit From Inhaled Insulin
Describe How to Initiate and Titrate Inhaled Insulin in Patients With Both Type 1 and Type 2 Diabetes

Credits
  • 1 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • 1 CPEUs
  • TARGET AUDIENCE

    NursingPharmacistHealthcare ProvidersEndocrinologistsHealthcare ProfessionalsNursesPrimary Care Physicians

    SPECIALITIES

    EndocrinologyEndocrinology, Metabolism and Diabetes

    TERMS & CONDITIONS

    Disclaimer:
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

    RELATED ONLINE COURSES

    3 Hours
    ...
    More actions

    Webcast

    Emergency Medicine
    More actions
    US$200